Market Overview

UPDATE: Compass Point Upgrades DR Horton to Neutral on Updated Forecasts

Share:
Related DHI
Benzinga's Top Initiations
18 Biggest Mid-Day Losers For Tuesday

Compass Point raised its rating on DR Horton (NYSE: DHI) from Sell to Neutral and raised its price target to $18.50.

Compass Point commented, "After a full model update we are raising estimates and, coupled with the stock's relative underperformance in the post-QE3 trade, we now feel DHI should perform in line with the rest of the space. Our price target increase reflects our increased 2013 EPS estimate to $0.93 from $0.87 as well as a consistent 5% assumed ROI. We still see downside in the shares to $18 but the stock is off 12% since the Fed announced QE3 in early September and has been the second worst performer in the homebuilding sector over that time frame."

DR Horton closed at $19.58 on Wednesday.

Latest Ratings for DHI

DateFirmActionFromTo
Nov 2016Evercore ISI GroupInitiates Coverage OnBuy
Sep 2016Wells FargoInitiates Coverage onOutperform
Sep 2016WedbushInitiates Coverage onOutperform

View More Analyst Ratings for DHI
View the Latest Analyst Ratings

Posted-In: Compass PointAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (DHI)

View Comments and Join the Discussion!